Clinical Trial Update: Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study investigating predictors of response to fluoxetine in individuals with combat-related posttraumatic stress …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: TEMPVA Research Group, Inc. | Conditions: Posttraumatic Stress Disorder, Combat-related | Phase 4 | Status: UNKNOWN